Chinese weight-correction model for maternal serum markers in Down syndrome prenatal screening

被引:2
作者
Wang, Yuan-Yuan
Zhang, Li
Peng, Zuo-Qi
Cui, Qin-Zi
Ma, Xu
机构
[1] Natl Res Inst Family Planning, Beijing 100081, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] WHO Collaborating Ctr Res Human Reprod, Beijing, Peoples R China
[4] Sheng Yang Maternal & Child Hlth Hosp, Liaoning, Peoples R China
关键词
Down syndrome; prenatal screening; regression model; weight-correction model;
D O I
10.1016/j.ijgo.2006.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the best weight-correction model by means of analyzing the relationship between maternal weight and maternal serum markers when screening for Down syndrome in China. Methods: Serum levels of (x-fetoprotein (AFP) and free beta-human chorionic gonadotropin (hCG) were measured in 35,917 Chinese women during the second semester of a normal singleton pregnancy and converted to multiple of median (MoM) values. Using 2 methods of statistical analysis, the all-point method and the median regression method, 4 weightcorrection models were then tried, the simple linear, reciprocal, quadratic, and log-linear regression models. Results: The median regression method performed better than the all-point method, and the quadratic regression model showed the best fit for both AFP and hCG in the median regression method, with adjusted R(2)s of 0.987 and 0.988, respectively. Conclusion: The quadratic regression model was found to be the most suitable for Chinese pregnant women. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 24 条
  • [1] AYME S, 1993, CONTRACEPT FERTIL S, V21, P133
  • [2] BROCK DJH, 1984, LANCET, V1, P1292
  • [3] BROCK DJH, 1977, LANCET, V1, P700
  • [4] Casals E, 1996, PRENATAL DIAG, V16, P405, DOI 10.1002/(SICI)1097-0223(199605)16:5<405::AID-PD868>3.0.CO
  • [5] 2-Y
  • [6] Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening
    Crossley, JA
    Aitken, DA
    Waugh, SML
    Kelly, T
    Connor, JM
    [J]. PRENATAL DIAGNOSIS, 2002, 22 (03) : 247 - 255
  • [7] ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL
    CUCKLE, HS
    WALD, NJ
    THOMPSON, SG
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05): : 387 - 402
  • [8] Hsu JJ, 1998, J MATERN-FETAL INVES, V8, P66
  • [9] Jou HJ, 2000, J FORMOS MED ASSOC, V99, P931
  • [10] Evaluation of different weight correction methods for antenatal serum screening using data from two multi-centre programmes
    Kennedy, DM
    Edwards, VM
    Worthington, DJ
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 : 359 - 364